STAAR Surgical (STAA) Tops Q1 EPS by 11c, Revenues Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
STAAR Surgical Reports Record First Quarter 2021 Net Sales of $50.8 Million Up 44% Y/Y
May 5, 2021 4:01 PM EDTFirst Quarter ICL Sales Up 58% Y/Y and Units Up 54% Y/Y
Announces Submission of Clinical Trial Data to U.S. FDA for EVO Family of Myopia Lenses
Introduces Net Sales Outlook of Approximately $215 Million to $217 Million for Full Year 2021
LAKE FOREST, Calif.--(BUSINESS WIRE)-- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today reported financial results for the first quarter ended April 2,... More



